欧盟 - 爱沙尼亚文 - EMA (European Medicines Agency)

bayer ag - aflibercept - wet macular degeneration; macular edema; diabetes complications - oftalmoloogilised vahendid - eylea on näidustatud täiskasvanute raviks:neovascular (märg) vanusega seotud makuladegeneratsiooni (amd);nägemispuudega tõttu macular turse teisejärguline võrkkesta veeni oklusioon (branch rvo-või kesk-rvo);nägemispuudega tõttu diabeediga macular turse (dme);nägemispuudega tõttu on lühinägelik choroidal neovascularisation (lühinägelik cnv).

爱沙尼亚 - 爱沙尼亚文 - Ravimiamet

teva b.v. - paklitakseel - infusioonilahuse kontsentraat - 6mg 1ml 50ml 1tk; 6mg 1ml 25ml 1tk; 6mg 1ml 5ml 1tk; 6mg 1ml 16.7ml 1tk

爱沙尼亚 - 爱沙尼亚文 - Ravimiamet

menarini international operations luxembourg s.a. - deksketoprofeen - süste-/infusioonilahus - 25mg 1ml 2ml 1tk; 25mg 1ml 2ml 5tk; 25mg 1ml 2ml 50tk; 25mg 1ml 2ml 10tk; 25mg 1ml 2ml 6tk

爱沙尼亚 - 爱沙尼亚文 - Ravimiamet

menarini international operations luxembourg s.a. - deksketoprofeen - õhukese polümeerikattega tablett - 25mg 500tk; 25mg 10tk; 25mg 30tk; 25mg 4tk; 25mg 50tk; 25mg 20tk

爱沙尼亚 - 爱沙尼亚文 - Ravimiamet

menarini international operations luxembourg s.a. - deksketoprofeen - õhukese polümeerikattega tablett - 12,5mg 40tk; 12,5mg 20tk; 12,5mg 500tk; 12,5mg 10tk

爱沙尼亚 - 爱沙尼亚文 - Ravimiamet

sandoz pharmaceuticals d.d. - raud(iii)hüdroksiid-dekstraankompleks - süstelahus - 50mg 1ml 2ml 50tk; 50mg 1ml 2ml 5tk

爱沙尼亚 - 爱沙尼亚文 - Ravimiamet

menarini international operations luxembourg s.a. - deksketoprofeen - graanulid kotikeses - 25mg 20tk; 25mg 4tk; 25mg 500tk; 25mg 100tk; 25mg 50tk; 25mg 30tk; 25mg 10tk; 25mg 2tk

欧盟 - 爱沙尼亚文 - EMA (European Medicines Agency)

samsung bioepis nl b.v. - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - oftalmoloogilised vahendid - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

爱沙尼亚 - 爱沙尼亚文 - Adama

adama - suspensioonikontsentraat - asoksüstrobiin - fungitsiidid

欧盟 - 爱沙尼亚文 - EMA (European Medicines Agency)

midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmoloogilised vahendid - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).